2025 Regular Session • Connecticut Legislature
HB06062: An Act Prohibiting Direct-to-consumer Prescription Drug Advertisements.
Legislative Summary
To prohibit direct-to-consumer prescription drug advertisements directed at consumers in this state.
Demographic Impact
Overall analysis of equity impact
Neutral
Medium ConfidenceView detailed demographic breakdown ↓Unlock Full Demographic Insights
Go beyond the overall score.
Gain a deeper understanding of this bill's potential impact across diverse communities, including detailed breakdowns by category and subgroup. Access to this granular analysis helps ensure equitable outcomes.
Enable full analysis features for your organization.
Contact Sales to Learn MoreOr email us directly at sales@legiequity.us.
Bill History
1/22/2025
Referred to Joint Committee on General Law
House of Representatives
2/3/2025
Vote to Draft
House of Representatives
2/11/2025
Drafted by Committee
House of Representatives
2/13/2025
Referred to Joint Committee on General Law
House of Representatives
2/14/2025
Public Hearing 02/19
House of Representatives
3/24/2025
Joint Favorable
House of Representatives
3/24/2025
Filed with Legislative Commissioners' Office
House of Representatives
4/2/2025
Referred to Office of Legislative Research and Office of Fiscal Analysis 04/07/25 5:00 PM
House of Representatives
4/8/2025
Reported Out of Legislative Commissioners' Office
House of Representatives
4/8/2025
Favorable Report, Tabled for the Calendar, House
House of Representatives
4/8/2025
House Calendar Number 363
House of Representatives
4/8/2025
File Number 589
House of Representatives
Roll Call Votes
GL Vote Tally Sheet (Joint Favorable)
3/24/2025
22
Yea
0
Nay
0
Not Voting
0
Absent
Result: PASSED
GL Vote Tally Sheet (Vote to Draft)
2/3/2025
0
Yea
0
Nay
0
Not Voting
0
Absent
Result: PASSED
Status Information
Current Status
Introduced(1/22/2025)
Chamber
House of Representatives
